Mesothelin-targeted alpha therapy in PDAC with [<sup>225</sup>Ac]Ac-Macropa-PEG<sub>6</sub>-AmatuximabDate unavailable
Substitution matters: Comparison of four N,1,4-tri(methoxy-2-hydroxybenzyl)-DAZA ligands as potential PET/CT liver imaging agentsDate unavailable